Notably, a significant difference in the methylation of the FMR1 promoter in the FXS- cohort compared to control hiDFPs was preserved following reprogramming, with FXS- lines exhibiting higher average methylation than control lines [t(3.00) = −11.45, p = 0.001; Figure 3B’]. This evidence concerns the gene FMR1 and fragile X syndrome.